Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

IRIS-Coroflex NEO Cohort

NCT: NCT06177743 · RECRUITING

NCT IDNCT06177743
StatusRECRUITING
Start Date2025-01-09
Completion2032-12-31
SponsorSeung-Jung Park (OTHER)
First posted
Last updated

Brief Summary

The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.

Frequently Asked Questions

What is IRIS-Coroflex NEO Cohort?

IRIS-Coroflex NEO Cohort is a clinical trial registered under NCT06177743. Current status: RECRUITING.

What is the status of NCT06177743?

The current status of NCT06177743 (IRIS-Coroflex NEO Cohort) is: RECRUITING.

When did IRIS-Coroflex NEO Cohort start?

IRIS-Coroflex NEO Cohort started on 2025-01-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.